申请人:Axial Therapeutics, Inc
公开号:US11147792B2
公开(公告)日:2021-10-19
The present disclosure provides methods and compositions for the prevention, amelioration, or alleviation of one or more neurological disorders associated with microbially-induced amyloid formation. Methods of inhibiting, ameliorating, reducing the likelihood, delaying the onset of, treating, or preventing an amyloid disorder are disclosed. Methods of identifying compounds capable of inhibiting the formation of microbially-induced amyloid fibrils are disclosed.
本公开提供了预防、改善或减轻与微生物诱导的淀粉样蛋白形成相关的一种或多种神经紊乱的方法和组合物。本发明公开了抑制、改善、降低淀粉样蛋白紊乱的可能性、延迟淀粉样蛋白紊乱的发生、治疗或预防淀粉样蛋白紊乱的方法。本发明公开了鉴定能够抑制微生物诱导的淀粉样纤维形成的化合物的方法。